Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a ...
MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...
Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 ...
Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.
Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three ...
Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to ...